Calla Sullivan

Ms. Calla Sullivan

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2025 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
OAOlamide Adebayo
Olamide Adebayo
BIBianca E. Ituarte
Bianca E. Ituarte
CSCalla Sullivan
Calla Sullivan
EWErin X. Wei
Erin X. Wei

31 December 2025 in Dermatopathology
Verified
Journal Article
Open access
PDF file
CSCalla Sullivan
Calla Sullivan
DDDominick DiMaio
Dominick DiMaio
LLLauer R Lauer
Lauer R Lauer
Dinesh PradhanDinesh Pradhan
Dinesh Pradhan
JYJulie Youngs
Julie Youngs
CGCorey J Georgesen
Corey J Georgesen
Accurate diagnosis of melanomas is crucial for proper evaluation and treatment. One immunohistochemical stain frequently utilized is PRAME (PReferentially expressed Antigen in MElanoma), a tumor-associated antigen expressed in most melanomas. This study aims to evaluate the reproducibility of PRAME scoring performed by dermatopathologists at an academic tertiary referral medical center. A blinded survey was designed featuring 21 melanocytic neoplasms stained with PRAME and H&E. For each case, five dermatopathologists provided a PRAME score from 0–4+, percent PRAME positivity, values for H-score, and a descriptive interpretation. Absolute agreement across raters was assessed using a Kappa statistic for PRAME score and intraclass correlations (ICCs) for H-score and PRAME percentage. Statistical analysis indicated poor inter-rater reliability for PRAME score (Kappa = 0.16), percent PRAME positivity (ICC = 0.31), and H-score (ICC = 0.40). Reporting language varied among pathologists. Our study demonstrated that the interpretation of PRAME immunohistochemistry lacks reproducibility, especially for challenging lesions. This suggests that a more rigorous, defined, and reproducible scoring method should be investigated for equivocal cases. Future studies may explore the utility of artificial intelligence software in the interpretation of PRAME for borderline lesions to improve reliability and standardize scoring.

1 September 2025 in Annals of Internal Medicine: Clinical Cases
Verified
Journal Article
Closed access
CSCalla Sullivan
Calla Sullivan
SKSrikanth Reddy Kothapalli
Srikanth Reddy Kothapalli
SHSafina Hafeez
Safina Hafeez
MKMeghana Kesireddy
Meghana Kesireddy